-
公开(公告)号:US20230414560A1
公开(公告)日:2023-12-28
申请号:US18323032
申请日:2023-05-24
发明人: Xiu-Min Li , Nan Yang , Zhenzhen Wang
IPC分类号: A61K31/353 , A61P17/00 , A61K31/231 , A61K31/232 , A61K31/015 , A61K31/575 , A61K31/122 , A61K31/19 , A61K31/215 , A61K31/365 , A61K31/366 , A61K31/12 , A61K31/7048 , A61K31/404 , A61K9/06 , A61K36/076 , A61K36/65 , A61K36/21 , A61K36/355 , A61K36/30 , A61K36/634 , A61K36/48 , A61K36/484 , A61K36/185 , A61K36/232 , A61K36/489
CPC分类号: A61K31/353 , A61P17/00 , A61K31/231 , A61K31/232 , A61K31/015 , A61K31/575 , A61K31/122 , A61K31/19 , A61K31/215 , A61K31/365 , A61K31/366 , A61K31/12 , A61K31/7048 , A61K31/404 , A61K9/06 , A61K36/076 , A61K36/65 , A61K36/21 , A61K36/355 , A61K36/30 , A61K36/634 , A61K36/48 , A61K36/484 , A61K36/185 , A61K36/232 , A61K36/489
摘要: A pharmaceutical composition for the treatment of eczema is disclosed. Also disclosed are methods of treating eczema in a subject by administering a pharmaceutical composition.
-
公开(公告)号:US20220354917A1
公开(公告)日:2022-11-10
申请号:US17870136
申请日:2022-07-21
申请人: LK. INC.
发明人: Jong Ryul LEE , Min Sub SIN , Young Min YUN
IPC分类号: A61K36/539 , A61K36/8968 , A61K36/489 , A61P17/00 , A61K36/756
摘要: The present invention relates to a pharmaceutical composition, a pharmaceutical composition for animals, and a food composition, each composition comprising a Scutellaria baicalensis extract, a Liriope platyphylla extract, a Sophora flavescens extract, a Dictamnus root bark extract, and a Phellodendron amurense Ruprecht extract, and preparation methods therefor.
-
公开(公告)号:US20220000956A1
公开(公告)日:2022-01-06
申请号:US17280069
申请日:2020-10-12
发明人: Xinliang WANG , Yina LU , Jun TIAN
IPC分类号: A61K36/539 , A61K36/489 , A61K36/484 , A61P29/00
摘要: An environmentally-friendly preparation method of a composition containing anti-inflammatory ingredients and use of the composition are provided. The method includes: S1. weighing a specified volume of water and adjusting the pH, adding Sophora flavescens roots, and subjecting a resulting mixture to extraction at a high temperature; S2. adjusting pH of an obtained solution in step S1, adding Glycyrrhiza inflata roots, and heating a resulting mixture to boiling for extraction; S3. adding Scutellaria baicalensis roots to an obtained boiling solution from the extraction in step S2, and subjecting a resulting mixture to extraction, filtration, and pH adjustment; S4. adding activated carbon to an obtained filtrate in step S3, and subjecting a resulting mixture to incubation and filtration; S5. adding a clarifying agent to an obtained filtrate in step S4, and subjecting a resulting mixture to standing and filtration; and S6. subjecting an obtained filtrate in step S5 to membrane separation.
-
公开(公告)号:US20210213089A1
公开(公告)日:2021-07-15
申请号:US17148808
申请日:2021-01-14
发明人: Jianqing GAO , Liming LI , Jiachen CHEN , Ping LI
IPC分类号: A61K36/489 , A61L27/36
摘要: Disclosed a plant-derived exosome as well as a preparation method and an application thereof in preparation of drugs or scaffolds for animal tissue regeneration therapy. The preparation method includes: soaking and infiltrating any part of a natural plant with a 2-(N-morpholine) ethanesulfonic acid buffer solution; removing a supernatant; collecting a wet treated sample; refrigerating, centrifuging and extracting the sample to obtain apoplastic fluid, wherein the soaking and infiltrating method is as follows: vacuum supply is performed within 6-24 h after soaking for 2-5 times, vacuum supply time is independently 5-15 s each time, and interval time between two adjacent times of vacuum supply is independently 10 s-1 min; and centrifuging the apoplastic fluid at an ultra-high speed to obtain the plant-derived exosome, wherein ultra-high speed centrifugation conditions are as follows: centrifugal force is not lower than 100000 g, centrifugation time is 1-7 h, and a temperature is 0-4° C.
-
公开(公告)号:US20210169961A1
公开(公告)日:2021-06-10
申请号:US17265724
申请日:2018-12-18
申请人: SHUGUANG HOSPITAL AFFILIATED TO SHANGHAI UNIVERSITY OF TRADITIONAL CHINESE MEDICINE , ACADEMY OF MILITARY MEDICAL SCIENCES , SHANGHAI SANG LUO MEDICINE TECHNOLOGY CO., LTD.
发明人: Yueqiu Gao , Junjie Shan , Xuehua Sun , Man Li , Yanxu Chen , Zhenhua Zhou , Yating Gao , Hao Ma , Xin Zhang , Rui Xu , Dan Nie , Lulu Liu , Changwei Li , Yu Yang , Xiunan Zhao
IPC分类号: A61K36/746 , A61K36/074 , A61K36/481 , A61K36/71 , A61K36/489 , A61K36/537 , A61K36/296 , A61K36/64 , A61K36/284 , A61K36/752 , A61K36/41 , A61K36/488 , A61K36/72 , A61K36/53 , A61K36/9066 , A61K35/586 , A61K36/8984 , A61K36/898 , A61K36/48 , A61K36/539 , A61K9/00 , A61K9/16 , A61K9/20 , A61K9/48 , A61P31/20 , A61P1/16 , A61P35/00 , A61K31/522 , A61K31/683 , A61K31/7072 , A61K31/506 , A23L33/105 , A23L33/00
摘要: Disclosed is a hepatoprotective traditional Chinese medicine composition, extract and pharmaceutical use thereof. The composition comprises Morinda officinalis How, Ganoderma lucidum (Leyss. Ex Fr.) Karst., Astragalus membranaceus (Fisch) Bge. Var. monghlicus (Bge) Hsiao, Ranunculus ternatus Thunb., Sophora flavescens Alt. and Salvia miltiorrhiza Bge. The composition and extract thereof may be used for treating liver injury, hepatitis, hepatic fibrosis, hepatic cirrhosis or liver cancer, and they may also be used as a vaccine adjuvant or an immunomodulator.
-
公开(公告)号:US20200289541A1
公开(公告)日:2020-09-17
申请号:US16885930
申请日:2020-05-28
发明人: Emi NISHIMURA , Hiroyuki Matsumura
IPC分类号: A61K31/713 , A61K38/55 , A61K36/05 , A61K36/14 , A61K36/47 , A61K36/48 , A61K36/54 , A61K8/97 , A61K31/506 , A61K36/489 , A61K36/738 , A61K36/04 , A61K36/424 , A61Q5/00 , A61K48/00 , A61K31/7088 , C12Q1/37 , A61K36/30 , A61K36/74 , A61K36/23 , A61K36/60 , A61K36/185 , A61Q7/00 , A61K36/718 , A61K36/488 , A61K36/53 , A61K36/82 , A61K39/395 , A61K36/18 , A61K36/28 , A61K31/222 , A61K45/00 , A61P17/14 , A61K31/05 , A61K31/16 , A61K31/355 , A61K31/375 , A61K31/381 , A61K31/7048
摘要: The present invention provides novel compositions for suppressing or improving hair loss, and compositions for suppressing or improving graying. More specifically, it provides agents that stabilize type XVII collagen expression, preferably agents that suppress the degradation of type XVII collagen by ELANE inhibitors and such, and compositions comprising a DNA repair-promoting agent or a DNA damage-suppressing agent as an active ingredient. Advantageous suppressive effects of hair loss and graying can be obtained when a composition comprising as an active ingredient a suppressive agent of type XVII collagen degradation such as an ELANE inhibitor is administered to a mammal. For the ELANE inhibitors, suppressive agents of type XVII collagen degradation and DNA repair-promoting agents, low-molecular compounds, polypeptides, proteins, antibodies, or nucleic acid medicine such as antisense oligos or siRNAs may be used. A method of screening for effective substances for suppression of hair loss and graying is also provided.
-
7.
公开(公告)号:US20190134140A1
公开(公告)日:2019-05-09
申请号:US15803608
申请日:2017-11-03
IPC分类号: A61K36/9066 , A61K9/00 , A61K31/12 , A61K31/05 , A61K36/70 , A61K31/352 , A61K36/23 , A61K36/489 , A61K31/4525 , A61K36/67 , A61K36/28 , A61K31/357 , A61K36/82 , A61K31/353 , A61K36/734 , A61K31/385 , A61K36/14 , A61K36/53 , A61K31/19 , A61K36/324 , A61K31/704 , A61K36/77
摘要: The invention relates to a new orally administered composition, which in present embodiments is a standardized phytochemical formulation but other embodiments may contain designed molecules. This formulation is capable of suppressing inflammation in a variety of disease conditions having an underlying inflammatory component, including but not limited to cystic fibrosis, COPD, asthma, and pancreatitis. It is an objective of the invention to provide a non-toxic therapy, which exhibits anti-oxidant anti-inflammatory properties without deleterious side effects.
-
公开(公告)号:US20170319475A1
公开(公告)日:2017-11-09
申请号:US14901060
申请日:2015-05-29
申请人: Darong LIU
发明人: Darong LIU
IPC分类号: A61K9/00 , A61K36/489 , A61K36/236 , A61K36/32 , A61K36/58 , A61K9/08 , A61K36/00
CPC分类号: A61K9/0053 , A61K9/0095 , A61K9/08 , A61K33/06 , A61K35/10 , A61K35/36 , A61K36/00 , A61K36/11 , A61K36/23 , A61K36/232 , A61K36/234 , A61K36/236 , A61K36/24 , A61K36/32 , A61K36/324 , A61K36/40 , A61K36/46 , A61K36/481 , A61K36/484 , A61K36/489 , A61K36/58 , A61K36/605 , A61K36/65 , A61K36/71 , A61K36/716 , A61K36/718 , A61K36/725 , A61K36/738 , A61K36/746 , A61K36/75 , A61K36/756 , A61K36/815 , A61K36/899 , A61K36/90 , A61K36/904 , A61K2300/00
摘要: The present invention discloses a medicine for treatment or adjuvant treatment of acquired immunodeficiency syndrome, a preparation method thereof and use methods thereof. The medicine comprises: lightyellow sophora root, glabrous greenbrier rhizome, bark of Chinese corktree, raw sessile stemona root, alumen, coptis root, cortex dictamni, chinaberry bark and root-bark, pangolin scales, amber, eucommia bark, tree peony bark, clematis root, common cnidium fruit, Chinese angelica, licorice root, common macrocarpium fruit, barbary wolfberry fruit, medicinal indianmulberry root, cherokee rose fruit, chinaroot greenbier rhizome, akebia fruit, milkvetch root, Japanese climbing fern spore, asiatic pennywort herb, mulberry leaf and frankincense. The present invention not only provides the medicine capable of effectively treating the acquired immunodeficiency syndrome, but also enables the medicine to be capable of being used in conjunction with other medical technical means to easily achieve a more ideal treatment effect.
-
公开(公告)号:US09801809B2
公开(公告)日:2017-10-31
申请号:US14703408
申请日:2015-05-04
IPC分类号: A61K36/00 , A61K8/97 , A61K8/60 , A61Q19/02 , A61K36/185 , A61K36/23 , A61K36/28 , A61K36/286 , A61K36/287 , A61K36/288 , A61K36/48 , A61K36/481 , A61K36/489
CPC分类号: A61K8/97 , A61K8/602 , A61K36/185 , A61K36/23 , A61K36/28 , A61K36/286 , A61K36/287 , A61K36/288 , A61K36/48 , A61K36/481 , A61K36/489 , A61K2800/70 , A61K2800/782 , A61Q19/02 , A61K2300/00
摘要: Compositions for topical use and having a melanin synthesis-inhibiting activity that include an amount of a botanical extract of at least one of Aspalathus Linearis, Matricaria, Saxifraga, Astragalus, Taraxacum officinale/mongolicum, Ferula varia/foetida, Carthamus tinctorius, Sophora flavescentis, or Chrysanthemum morifolium effective to reduce melanin synthesis are described. Methods for inhibiting melanin synthesis and for skin whitening are also described.
-
10.
公开(公告)号:US09724375B2
公开(公告)日:2017-08-08
申请号:US14596297
申请日:2015-01-14
申请人: The Dial Corporation
IPC分类号: A61K36/00 , A61K36/489 , A61K36/355 , A61K36/484 , A61K36/488 , A61K8/97 , A61K9/00 , A61Q19/00
CPC分类号: A61K36/489 , A61K8/97 , A61K9/0014 , A61K36/355 , A61K36/484 , A61K36/488 , A61K2800/30 , A61K2800/5922 , A61Q19/00 , A61K2300/00
摘要: The present invention comprises mixtures of herb extracts which exert synergistic antioxidant effect and comprise the herb sophora and licorice. Skin care preparations incorporating such herb extract mixtures, and their methods of preparation and use, are also claimed.
-
-
-
-
-
-
-
-
-